ConductScience.org, home

Comparison · NCT00524472-ce5b6f0c

Hyperinsulinemic-normoglycemic Clamp vs Insulin at the Standard of Care Levels: All-cause Mortality

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Hyperinsulinemic-normoglycemic Clamp vs Insulin at the Standard of Care Levels: All-cause Mortality. Trial comparisons, record NCT00524472-ce5b6f0c. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT00524472-ce5b6f0c

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.0490.03490.0684wilson
Risk in group 20.03230.02140.0484wilson
Risk difference, group 1 minus group 20.0167-0.004640.0389newcombe hybrid score
Risk ratio, group 1 over group 21.520.8922.59log
Odds ratio, group 1 over group 21.550.8892.69log
Number needed to treat, for one more participant with the outcome on Hyperinsulinemic-normoglycemic Clamp than on Insulin at the Standard of Care Levels59.7from the risk difference intervalthe interval includes no difference

Groups2

Group 2 names the comparator: standard of care.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Hyperinsulinemic-normoglycemic Clamp
Patients will be randomized to receive the hyperinsulinemic-normoglycemic clamp titrating the blood glucose to 80-110 mg/dL.~Hyperinsulinemic-normoglycemic clamp: Patients will be randomized to receive the hyperinsulinemic-normoglycemic clamp titrating the blood glucose to 80-110 mg/dL.
32653OG000
Group 2Insulin at the Standard of Care Levels
Group B will be administered insulin at the standard of care levels established by the participating institution.~insulin at the standard of care levels: Subjects will be administered insulin at the standard of care levels established by the participating institution.
22682OG001

Outcome

Type
SECONDARY
Title
All-cause Mortality
Description
All-cause mortality identified during one-year follow-up.
Time frame
one year post operative
Population

Source ClinicalTrials.gov

Trial

Title
Outcomes Study of Hyperinsulinemic Glucose Control in Cardiac Surgery
NCT number
NCT00524472
Phases
NA
Conditions
Cardiac Surgery
Interventions
Hyperinsulinemic-normoglycemic clamp, insulin at the standard of care levels
Lead sponsor
The Cleveland Clinic
Results first posted
2018-10-26

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT00524472-ce5b6f0c